GMJ Briefs
New Data Highlights Vaccine Effectiveness Gap: Why Enhanced Formulations Matter
Flu vaccine effectiveness plummets to 25% in adults 65+, driving regulatory approval of enhanced adjuvanted formulation.
Cellular Dysfunction, Not Tumors Alone, Drives NF1 Pain, Cincinnati Study Reveals
Cincinnati Children's research reveals NF1 pain originates from abnormal Schwann cell signaling before tumors develop.
Data Alert: FDA Issues Nearly Four Device Safety Communications Monthly in 2024
FDA issued an average of 3.9 medical device safety alerts monthly in 2024, demonstrating consistent regulatory oversight.
What Patients Should Know About This Emerging Vision Correction Alternative
New electrical vision correction technology offers reversibility, rapid treatment, and corneal preservation compared to traditional refractive surgery approaches.
South Sudan’s Perfect Storm: How Conflict, Climate, and Economics Collide in Humanitarian Catastrophe
South Sudan faces a Grade 3 humanitarian emergency driven by conflict, climate shocks, and economic collapse affecting 7.8 million people.
Data Shows Dramatic Improvement in Care Leaver Outcomes with Supported Housing
Supported housing achieves 85% housing stability versus 45% with traditional discharge, alongside 35% improvement in mental health outcomes.
What Criminal Justice Systems Should Learn from Moldova’s Opioid Screening Success
Moldova study demonstrates probation centres can effectively screen for and treat opioid addiction with 97% treatment retention.
What Hunters and Consumers Need to Know: Health Risks Beyond the Field
WOAH identifies three key considerations: widespread lead poisoning deaths, human health risks from wild game consumption, and readily available non-toxic…